{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T10:55:04Z","timestamp":1793876104565,"version":"4.7.0"},"reference-count":212,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T00:00:00Z","timestamp":1552262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001263","name":"National Philanthropic Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["203160\/Z\/16\/Z"],"award-info":[{"award-number":["203160\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005624","name":"PATH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005624","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.vaccine.2019.01.011","type":"journal-article","created":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T17:36:13Z","timestamp":1556904973000},"page":"85-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":152,"title":["Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1647-2355","authenticated-orcid":false,"given":"Carleigh B.","family":"Krubiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth R.","family":"Faden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth A.","family":"Karron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret O.","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne D.","family":"Lyerly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon S.","family":"Abramson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard H.","family":"Beigi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro R.","family":"Cravioto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna P.","family":"Durbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce G.","family":"Gellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati B.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Kaslow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1150-5691","authenticated-orcid":false,"given":"Sonali","family":"Kochhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florencia","family":"Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Saenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne S.","family":"Sheffield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina O.","family":"Tindana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2019.01.011_b0005","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1353\/bhm.2002.0022","article-title":"Updating the accounts: global mortality of the 1918\u20131920\u201c Spanish\u201d influenza pandemic","volume":"76","author":"Johnson","year":"2002","journal-title":"Bull Hist Med"},{"issue":"4","key":"10.1016\/j.vaccine.2019.01.011_b0010","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/AOG.0b013e3181d57947","article-title":"Severity of 2009 pandemic influenza A (H1N1) virus infection in pregnant women","volume":"115","author":"Creanga","year":"2010","journal-title":"Obstet & Gynec"},{"issue":"3","key":"10.1016\/j.vaccine.2019.01.011_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(15)70009-4","article-title":"Ebola crisis: the unequal impact on women and children's health","volume":"3","author":"Men\u00e9ndez","year":"2015","journal-title":"Lancet Glob Health"},{"issue":"11","key":"10.1016\/j.vaccine.2019.01.011_b0020","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.3201\/eid1211.060152","article-title":"Emerging infections and pregnancy","volume":"12","author":"Jamieson","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"24","key":"10.1016\/j.vaccine.2019.01.011_b0025","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1056\/NEJMoa1602412","article-title":"Zika virus infection in pregnant women in Rio de Janeiro","volume":"375","author":"Brasil","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2019.01.011_b0030","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jamapediatrics.2016.3982","article-title":"Characterizing the pattern of anomalies in congenital zika syndrome for pediatric clinicians","volume":"171","author":"Moore","year":"2017","journal-title":"JAMA Pediatr"},{"issue":"9","key":"10.1016\/j.vaccine.2019.01.011_b0035","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3389\/fimmu.2018.00436","article-title":"Current challenges and achievements in maternal immunization research","volume":"6","author":"Munoz","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2019.01.011_b0040","unstructured":"World Health Organization (WHO). Guidance for managing ethical issues in infectious disease outbreaks. World Health Organization. 2016. Accessed August 1, 2018. Available from: http:\/\/www.who.int\/ethics\/publications\/infectious-disease-outbreaks\/en\/."},{"key":"10.1016\/j.vaccine.2019.01.011_b0045","unstructured":"Pan American Health Organization (PAHO). Zika ethics consultation: ethics guidance on key issues raised by the outbreak [Internet]; 2016. Available from: http:\/\/iris.paho.org\/xmlui\/handle\/123456789\/28425."},{"key":"10.1016\/j.vaccine.2019.01.011_b0050","unstructured":"Council for International Organizations of Medical Sciences (CIOMS), World Health Organization (WHO). International ethical guidelines for health-related research involving humans. Geneva, Switzerland: Council for international organizations of medical sciences [Internet]. 2016. Available from: http:\/\/cioms.ch\/ethical-guidelines-2016\/WEB-CIOMS-EthicalGuidelines.pdf."},{"issue":"5","key":"10.1016\/j.vaccine.2019.01.011_b0055","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1097\/AOG.0000000000001150","article-title":"ACOG committee opinion no. 646: ethical considerations for including women as research participants","volume":"126","author":"American College of Obstetricians and Gynecologists","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2019.01.011_b0060","unstructured":"U.S. Department of Health and Human Services. Charter: task force on research specific to pregnant women and lactating women (PRGLAC). 2017. Accessed 27 June 2018. Available from: https:\/\/www.nichd.nih.gov\/sites\/default\/files\/2017-09\/PRGLAC_Signed_Charter_201704.pdf."},{"key":"10.1016\/j.vaccine.2019.01.011_b0065","unstructured":"U.S. department of health and human services, food and drug administration (FDA), center for drug evaluation and research (CDER). Pregnant women: scientific and ethical considerations for inclusion in clinical trials guidance for industry. Revision 1. April 2018. Accessed 27 June 2018. Available from: https:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM603873.pdf."},{"issue":"2","key":"10.1016\/j.vaccine.2019.01.011_b0070","first-page":"5","article-title":"The second wave: Toward responsible inclusion of pregnant women in research","volume":"1","author":"Lyerly","year":"2008","journal-title":"IJFAB: Int J Fem Approaches Bioeth"},{"key":"10.1016\/j.vaccine.2019.01.011_b0075","series-title":"Clinical research involving pregnant women","year":"2017"},{"key":"10.1016\/j.vaccine.2019.01.011_b0080","first-page":"14(3)","year":"2017","journal-title":"[Supplement] Reprod Health"},{"issue":"41","key":"10.1016\/j.vaccine.2019.01.011_b0085","article-title":"Un llamado \u00e9tico a la inclusi\u00f3n de mujeres embarazadas en investigaci\u00f3n: Reflexiones del Foro Global de Bio\u00e9tica en Investigaci\u00f3n","volume":"26","author":"Saenz","year":"2018","journal-title":"Revista Panamericana de Salud P\u00fablica"},{"key":"10.1016\/j.vaccine.2019.01.011_b0090","unstructured":"World Health Organization (WHO). Maternal immunization and antenatal care service delivery situation analysis project. http:\/\/www.who.int\/maternal_child_adolescent\/topics\/maternal\/immunization-antenatal-care-delivery\/en\/."},{"key":"10.1016\/j.vaccine.2019.01.011_b0095","unstructured":"PATH. The advancing maternal immunization collaboration. https:\/\/path.org\/resources\/the-advancing-maternal-immunization-collaboration\/."},{"issue":"7","key":"10.1016\/j.vaccine.2019.01.011_b0100","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(17)30230-X","article-title":"Global perspectives on maternal immunisation","volume":"17","author":"Meulen","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.01.011_b0105","first-page":"5991","volume":"34(49)","year":"2016","journal-title":"[Special Issue] Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.011_b0110","first-page":"6469","volume":"35(48)","year":"2017","journal-title":"[Special Issue] Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.011_b0115","unstructured":"Kass N, Kahn J, Buckland A, Paul A, and the Expert Working Group. Ethics guidance for the public health containment of serious infectious disease outbreaks in low-income settings: lessons from Ebola. [Forthcoming, 2018] (funded by the Wellcome Trust Grant 109291\/Z\/15\/Z)."},{"key":"10.1016\/j.vaccine.2019.01.011_b0120","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJMp1506820","article-title":"Establishing a global vaccine-development fund","volume":"373","author":"Plotkin","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.01.011_b0125","unstructured":"World Health Organization (WHO). An R&D blueprint for action to prevent epidemic - plan of action May 2016; 2016."},{"key":"10.1016\/j.vaccine.2019.01.011_b0130","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMp1613577","article-title":"New vaccines against epidemic infectious diseases","author":"R\u00f8ttingen","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.01.011_b0135","first-page":"201701410","article-title":"Emerging infectious diseases: a proactive approach","author":"Bloom","year":"2017","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2019.01.011_b0140","unstructured":"Coalition for Epidemic Preparedness (CEPI). Draft equitable access policy. 2018. Available from: http:\/\/cepi.net\/request-public-comments-cepi%E2%80%99s-equitable-access-policy. Accessed 1 August 2018."},{"key":"10.1016\/j.vaccine.2019.01.011_b0145","unstructured":"Gavi. Vaccine Investment Strategy: Evaluation criteria for vaccines for epidemic preparedness and response. Available from: https:\/\/www.gavi.org\/about\/strategy\/vaccine-investment-strategy\/. Accessed 1 August 2018."},{"issue":"3","key":"10.1016\/j.vaccine.2019.01.011_b0150","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12978-017-0430-2","article-title":"Protected to death: systematic exclusion of pregnant women from Ebola virus disease trials","volume":"14","author":"Gomes","year":"2017","journal-title":"Reprod Health"},{"issue":"9744","key":"10.1016\/j.vaccine.2019.01.011_b0155","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(10)61030-6","article-title":"Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial","volume":"376","author":"Zhu","year":"2010","journal-title":"The Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2019.01.011_b0160","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1728-4465.2014.00393.x","article-title":"Intended and unintended pregnancies worldwide in 2012 and recent trends","volume":"45","author":"Sedgh","year":"2014","journal-title":"Stud Fam Plann"},{"key":"10.1016\/j.vaccine.2019.01.011_b0165","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/bdra.23558","article-title":"Ebola virus disease and pregnancy: a review of the current knowledge of ebola virus pathogenesis, maternal, and neonatal outcomes","volume":"109","author":"Bebell","year":"2017","journal-title":"Birth Defects Res"},{"issue":"1","key":"10.1016\/j.vaccine.2019.01.011_b0170","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/GRF.0000000000000332","article-title":"Ebola infection in pregnancy: a global perspective and lessons learned","volume":"61","author":"Haddad","year":"2018","journal-title":"Clin Obstet Gynecol"},{"issue":"9707","key":"10.1016\/j.vaccine.2019.01.011_b0175","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(09)61877-8","article-title":"Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines","volume":"374","author":"Black","year":"2009","journal-title":"The Lancet"},{"issue":"10","key":"10.1016\/j.vaccine.2019.01.011_b0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046638","article-title":"Background rates of adverse pregnancy outcomes for assessing the safety of maternal vaccine trials in sub-saharan Africa","volume":"7","author":"Orenstein","year":"2012","journal-title":"PLoS One"},{"issue":"24","key":"10.1016\/j.vaccine.2019.01.011_b0185","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1002\/ajmg.a.32077","article-title":"Emerging infections and pregnancy: assessing the impact on the embryo or fetus","volume":"143A","author":"Rasmussen","year":"2007","journal-title":"Am J Med Genet A"},{"issue":"5","key":"10.1016\/j.vaccine.2019.01.011_b0190","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/bdr2.1006","article-title":"Studying the effects of emerging infections on the fetus: Experience with West Nile and Zika viruses","volume":"109","author":"Rasmussen","year":"2017","journal-title":"Birth Defects Res"},{"issue":"5","key":"10.1016\/j.vaccine.2019.01.011_b0195","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/bdr2.1007","article-title":"Population-based pregnancy and birth defects surveillance in the era of Zika virus","volume":"109","author":"Gilboa","year":"2017","journal-title":"Birth Defects Res"},{"issue":"1","key":"10.1016\/j.vaccine.2019.01.011_b0200","doi-asserted-by":"crossref","first-page":"34.e1","DOI":"10.1016\/j.ajog.2016.08.031","article-title":"A call for science preparedness for pregnant women during public health emergencies","volume":"216","author":"Faherty","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"48Part A","key":"10.1016\/j.vaccine.2019.01.011_b0205","doi-asserted-by":"crossref","first-page":"6472","DOI":"10.1016\/j.vaccine.2017.01.044","article-title":"Congenital microcephaly: Case definition & guidelines for data collection, analysis, and presentation of safety data after maternal immunisation","volume":"35","author":"DeSilva","year":"2017","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2019.01.011_b0210","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJM198807283190401","article-title":"Incidence of early loss of pregnancy","volume":"319","author":"Wilcox","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.01.011_b0215","unstructured":"American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 150: Clinical Management Guidelines for Obstetrician-Gynecologists. Early Pregnancy Loss. 2015 May (Reaffirmed 2017). Available from: https:\/\/www.acog.org\/-\/media\/Practice-Bulletins\/Committee-on-Practice-Bulletins----Gynecology\/Public\/pb150.pdf?dmc=1&ts=20180808T0016428143."},{"issue":"5","key":"10.1016\/j.vaccine.2019.01.011_b0220","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1053\/beog.2000.0123","article-title":"Epidemiology and the medical causes of miscarriage","volume":"14","author":"Regan","year":"2000","journal-title":"Baillieres Best Pract Res Clin Obstet Gynaecol"},{"issue":"48","key":"10.1016\/j.vaccine.2019.01.011_b0225","doi-asserted-by":"crossref","first-page":"6563","DOI":"10.1016\/j.vaccine.2017.01.047","article-title":"Spontaneous abortion and ectopic pregnancy: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data","volume":"35","author":"Rouse","year":"2017","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2019.01.011_b0230","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/AOG.0b013e3182a1118a","article-title":"Inactivated influenza vaccine during pregnancy and risks for adverse obstetric events","volume":"122","author":"Kharbanda","year":"2013","journal-title":"Obstet & Gynecol"},{"issue":"10032","key":"10.1016\/j.vaccine.2019.01.011_b0235","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/S0140-6736(15)00519-X","article-title":"Countdown to 2015: a decade of tracking progress for maternal, newborn, and child survival","volume":"387","author":"Victora","year":"2016","journal-title":"The Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2019.01.011_b0240","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1742-4755-12-S2-S1","article-title":"The global network maternal newborn health registry: a multi-national, community-based registry of pregnancy outcomes","volume":"12","author":"Bose","year":"2015","journal-title":"Reprod Health"},{"issue":"49","key":"10.1016\/j.vaccine.2019.01.011_b0245","doi-asserted-by":"crossref","first-page":"5991","DOI":"10.1016\/j.vaccine.2016.08.026","article-title":"Obstetrical and neonatal case definitions for immunization safety data","volume":"34","author":"Chen","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.011_b0250","unstructured":"World Health Organization (WHO) SAGE immunization. Report of the SAGE working group on vaccine hesitancy. 2014 Oct 1. Available from: http:\/\/www.who.int\/immunization\/sage\/meetings\/2014\/october\/SAGE_working_group_revised_report_vaccine_hesitancy.pdf?ua=1."},{"issue":"19","key":"10.1016\/j.vaccine.2019.01.011_b0255","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.vaccine.2014.01.081","article-title":"Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007\u20132012","volume":"32","author":"Larson","year":"2014","journal-title":"Vaccine"},{"issue":"just-accepted","key":"10.1016\/j.vaccine.2019.01.011_b0260","first-page":"01","article-title":"Measuring trust in vaccination: A systematic review","volume":"29","author":"Larson","year":"2018","journal-title":"Hum Vaccin Immunother"},{"issue":"47","key":"10.1016\/j.vaccine.2019.01.011_b0265","doi-asserted-by":"crossref","first-page":"6420","DOI":"10.1016\/j.vaccine.2015.08.046","article-title":"Understanding factors influencing vaccination acceptance during pregnancy globally: a literature review","volume":"33","author":"Wilson","year":"2015","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2019.01.011_b0270","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1353\/hcr.0.0211","article-title":"Risk and the pregnant body","volume":"39","author":"Lyerly","year":"2009","journal-title":"Hastings Cent Rep"},{"issue":"38","key":"10.1016\/j.vaccine.2019.01.011_b0275","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.15585\/mmwr.mm6638a2","article-title":"Influenza vaccination coverage among pregnant women-United States, 2016\u201317 influenza season","volume":"66","author":"Ding","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.vaccine.2019.01.011_b0280","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1080\/21645515.2015.1101524","article-title":"Improving rates of maternal immunization: challenges and opportunities","volume":"12","author":"MacDougall","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"47","key":"10.1016\/j.vaccine.2019.01.011_b0285","doi-asserted-by":"crossref","first-page":"6376","DOI":"10.1016\/j.vaccine.2015.08.036","article-title":"A global perspective of maternal influenza immunization","volume":"33","author":"Lambach","year":"2015","journal-title":"Vaccine"},{"issue":"41","key":"10.1016\/j.vaccine.2019.01.011_b0290","doi-asserted-by":"crossref","first-page":"5445","DOI":"10.1016\/j.vaccine.2015.08.028","article-title":"Knowledge and attitiudes of pregnant women and their providers towards recommendations for immunization during pregnancy","volume":"33","author":"Healy","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.011_b0295","unstructured":"World Health Organization (WHO), PATH. Maternal influenza immunization: Guidance to inform introduction of influenza vaccine in low and middle-income countries. Accessed 23 April 2018. Available from: http:\/\/www.who.int\/immunization\/research\/development\/influenza_maternal_immunization\/en\/."},{"key":"10.1016\/j.vaccine.2019.01.011_b0300","unstructured":"Maharashtra Association of Anthropological Sciences, Swiss Tropical and Public Health Institute. Project protocol to assess awareness and acceptance of maternal influenza vaccination in low-resource settings. Commissioned by WHO. 2016. Accessed 23 April 2018. Available from: http:\/\/www.who.int\/immunization\/research\/development\/Project_Protocol_Annexures.pdf?ua=1."},{"key":"10.1016\/j.vaccine.2019.01.011_b0305","unstructured":"Pan American Health Organization (PAHO). Maternal and neonatal immunization field guide for latin America and the caribbean. Washington, D.C.: PAHO; 2017. Accessed 23 April 2018. Available from: http:\/\/iris.paho.org\/xmlui\/handle\/123456789\/34150."},{"key":"10.1016\/j.vaccine.2019.01.011_b0310","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6120701","article-title":"Efforts to improve immunization coverage during pregnancy among ob-gyns","author":"Jones","year":"2016","journal-title":"Infect Dis Obstet Gynecol 2016"},{"key":"10.1016\/j.vaccine.2019.01.011_b0315","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0301-2115(00)00375-4","article-title":"Perception of teratogenic risk of common medicines","volume":"95","author":"Sanz","year":"2001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.vaccine.2019.01.011_b0320","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.3201\/eid1211.060618","article-title":"Prophylaxis and treatment of pregnant women for emerging infections andbioterrorism emergencies","volume":"12","author":"Cono","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2019.01.011_b0325","unstructured":"World Health Organization (WHO). Communicating risk in public health emergencies: a WHO guideline for emergency risk communication (ERC) policy and practice. Geneva: World Health Organization; 2017. License: CC BY-NC-SA 3.0 IGO."},{"key":"10.1016\/j.vaccine.2019.01.011_b0330","unstructured":"Council for International Organizations of Medical Sciences (CIOMS). CIOMS guide to vaccine safety communication: report by topic group 3 of the CIOMS working group on vaccine safety. CIOMS. Geneva, Switzerland; 2018."},{"key":"10.1016\/j.vaccine.2019.01.011_b0335","unstructured":"U.S. Institute of Medicine (IOM). Characterizing and communicating uncertainty in the assessment of benefits and risks of pharmaceutical products - workshop summary. Washington, DC: The National Academies Press; 2014.IOM Report."},{"key":"10.1016\/j.vaccine.2019.01.011_b0340","unstructured":"U.S. Institute of Medicine (IOM), vaccine safety forum. Risk communication and vaccination: summary of a workshop. Washington, DC: The National Academies Press; 1997."},{"key":"10.1016\/j.vaccine.2019.01.011_b0345","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/157488631001150407110435","article-title":"Communicating vaccine safety during the development and introduction of vaccines","volume":"10","author":"Kochhar","year":"2015","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.vaccine.2019.01.011_b0350","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1186\/s12889-017-4618-8","article-title":"Controversial vaccine trials in Ghana","volume":"17","author":"Kummervold","year":"2017","journal-title":"BMC Public Health"},{"issue":"6, Supplement","key":"10.1016\/j.vaccine.2019.01.011_b0355","first-page":"S112","article-title":"Uptake of influenza vaccine in pregnant women during the 2009 H1N1 influenza pandemic","volume":"204","author":"Goldfarb","year":"2011","journal-title":"Emerg Issues Prev Detect Treat Influenza Pregnant Women U S"},{"issue":"3","key":"10.1016\/j.vaccine.2019.01.011_b0360","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.ajog.2012.06.077","article-title":"Influenza immunization in pregnancy: overcoming patient and health care provider barriers","volume":"207","author":"Shavell","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2019.01.011_b0365","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ajic.2016.11.025","article-title":"Despite awareness of recommendations, why do health care workers not immunize pregnant women?","volume":"45","author":"Gesser-Edelsburg","year":"2017","journal-title":"Am J Infect Control"},{"issue":"8","key":"10.1016\/j.vaccine.2019.01.011_b0370","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/jamapediatrics.2017.1496","article-title":"Rubella and Zika vaccine research\u2014a cautionary tale about caution","volume":"171","author":"Lyerly","year":"2017","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.vaccine.2019.01.011_b0375","unstructured":"Ding H, Black C, Ball S, et al. Pregnant women and flu vaccination, internet panel survey, United States, November 2017. Centers for disease control and prevention. Accessed 29 January 26, 2018. https:\/\/www.cdc.gov\/flu\/fluvaxview\/pregnant-women-nov2017.htm."},{"issue":"suppl 7","key":"10.1016\/j.vaccine.2019.01.011_b0380","doi-asserted-by":"crossref","first-page":"S408","DOI":"10.1093\/cid\/ciu708","article-title":"Maternal immunization: opportunities for scientific advancement","volume":"59","author":"Beigi","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"40","key":"10.1016\/j.vaccine.2019.01.011_b0385","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.1016\/j.vaccine.2017.06.069","article-title":"Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010\u201311 and 2011\u201312","volume":"35","author":"Donahue","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.011_b0390","unstructured":"Sun L. What to know about a study of flu vaccine and miscarriage. The Washington Post. September 13; 2017."},{"key":"10.1016\/j.vaccine.2019.01.011_b0395","unstructured":"Associated Press. Study prompts call to examine flu vaccine and miscarriage. September 13; 2017."},{"key":"10.1016\/j.vaccine.2019.01.011_b0400","unstructured":"Brown H. It is safe to receive flu shot during pregnancy. ACOG Communications Office. September 13, 2017. Accessed at https:\/\/www.acog.org\/About-ACOG\/News-Room\/Statements\/2017\/It-is-Safe-to-Receive-Flu-Shot-During-Pregnancy."},{"key":"10.1016\/j.vaccine.2019.01.011_b0405","unstructured":"Centers for Disease Control and Prevention (CDS). Flu vaccination & possible safety signal: information & guidance for health care providers. September 13, 2017. Accessed at https:\/\/www.cdc.gov\/flu\/professionals\/vaccination\/vaccination-possible-safety-signal.html."},{"issue":"5","key":"10.1016\/j.vaccine.2019.01.011_b0410","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/AOG.0000000000002573","article-title":"Influenza vaccination, pregnancy safety, and risk of early pregnancy loss","volume":"131","author":"Sperling","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2019.01.011_b0415","unstructured":"Humans Vaccines Project. SCIENTIFIC PLAN: Determining the rules of the human immune system [internet] Available from http:\/\/www.humanvaccinesproject.org\/work\/scientific-plan\/rules-of-immunogenicity-program\/."},{"key":"10.1016\/j.vaccine.2019.01.011_b0420","unstructured":"U.S. National Insitutites of Health (NIH). Immune mechanisms at the maternal-fetal interface (R01 clinical trial optional). Funding opportunity announcement (FOA) Number. RFA-AI-18-023. https:\/\/grants.nih.gov\/grants\/guide\/rfa-files\/RFA-AI-18-023.html."},{"issue":"3","key":"10.1016\/j.vaccine.2019.01.011_b0425","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/hast.706","article-title":"Research with pregnant women: new insights on legal decision-making","volume":"47","author":"Mastroianni","year":"2017","journal-title":"Hastings Cent Rep"},{"key":"10.1016\/j.vaccine.2019.01.011_b0430","unstructured":"Coalition for Epidemic Preparedness (CEPI) [webpage] Accessed 20 April 2018. http:\/\/cepi.net\/approach."},{"issue":"3","key":"10.1016\/j.vaccine.2019.01.011_b0435","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1377\/hlthaff.24.3.697","article-title":"Encouraging the development of new vaccines","volume":"24","author":"Grabowski","year":"2005","journal-title":"Health Aff"},{"key":"10.1016\/j.vaccine.2019.01.011_b0440","unstructured":"U.S. Department of Health and Human Services (HHS). Tropical disease priority review vouchers: guidance for industry; 2016."},{"key":"10.1016\/j.vaccine.2019.01.011_b0445","unstructured":"Public readiness and emergency preparedness (PREP) Act. 42. Sect. 247d-6d, 247d-6e., P.L. No.109-148."},{"key":"10.1016\/j.vaccine.2019.01.011_b0450","unstructured":"Pandemic and all-hazards preparedness reauthorization act of 2013 (PAHPRA) [Internet]. P.L. No.113-5, 127 Stat 161 2013. Available from: https:\/\/www.fda.gov\/EmergencyPreparedness\/Counterterrorism\/MedicalCountermeasures\/MCMLegalRegulatoryandPolicyFramework\/ucm359581.htm."},{"issue":"12","key":"10.1016\/j.vaccine.2019.01.011_b0455","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001911","article-title":"The Ebola vaccine, iatrogenic injuries, and legal liability","volume":"12","author":"Attaran","year":"2015","journal-title":"PLoS Med"},{"issue":"5","key":"10.1016\/j.vaccine.2019.01.011_b0460","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jama.2016.19492","article-title":"A global vaccine injury compensation system","volume":"317","author":"Halabi","year":"2017","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.vaccine.2019.01.011_b0465","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1503\/cmaj.070610","article-title":"Protecting vaccine programs and the public","volume":"176","author":"Wilson","year":"2007","journal-title":"CMAJ"},{"key":"10.1016\/j.vaccine.2019.01.011_b0470","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(18)30063-X","article-title":"Development of vaccines against Zika virus","author":"Poland","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.01.011_b0475","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/01.ede.0000152903.55579.15","article-title":"Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and meta-analysis","volume":"1","author":"Moretti","year":"2005","journal-title":"Epidemiology"},{"key":"10.1016\/j.vaccine.2019.01.011_b0480","first-page":"peds-2013","article-title":"Systematic review and meta-analyses: fever in pregnancy and health impacts in the offspring","volume":"1","author":"Dreier","year":"2014","journal-title":"Pediatrics"},{"issue":"500","key":"10.1016\/j.vaccine.2019.01.011_b0485","doi-asserted-by":"crossref","first-page":"eaal4055","DOI":"10.1126\/scisignal.aal4055","article-title":"Temperature-activated ion channels in neural crest cells confer maternal fever\u2013associated birth defects","volume":"10","author":"Hutson","year":"2017","journal-title":"Sci Signal"},{"issue":"11","key":"10.1016\/j.vaccine.2019.01.011_b0490","doi-asserted-by":"crossref","first-page":"e1011","DOI":"10.1016\/j.ijid.2013.05.015","article-title":"Containing a Lassa fever epidemic in a resource-limited setting: outbreak description and lessons learned from Abakaliki, Nigeria (January\u2013March 2012)","volume":"17","author":"Ajayi","year":"2013","journal-title":"Int J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2019.01.011_b0495","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/trstmh\/tru009","article-title":"Constraints in the diagnosis and treatment of Lassa fever and the effect on mortality in hospitalized children and women with obstetric conditions in a rural district hospital in Sierra Leone","volume":"108","author":"Dahmane","year":"2014","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2019.01.011_b0500","unstructured":"World Health Organization (WHO) lassa fever fact sheet. Available from: http:\/\/www.who.int\/mediacentre\/factsheets\/fs179\/en\/."},{"issue":"12","key":"10.1016\/j.vaccine.2019.01.011_b0505","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s40264-017-0566-6","article-title":"The ribavirin pregnancy registry: an interim analysis of potential teratogenicity at the mid-point of enrollment","volume":"40","author":"Sinclair","year":"2017","journal-title":"Drug Saf"},{"key":"10.1016\/j.vaccine.2019.01.011_b0510","unstructured":"CEPI pipeline dataset, Lassa. Updated August 2017. Accessed 20 April 2018. Available from: http:\/\/cepi.net\/sites\/default\/files\/PDF%20Pipeline%20dataset%20Lassa%20Aug2017.pdf."},{"key":"10.1016\/j.vaccine.2019.01.011_b0515","unstructured":"CEPI. A global insurance policy to defend against future epidemics (booklet). Accessed August 1, 2018. Available from: http:\/\/cepi.net\/sites\/default\/files\/CEPI%20booklet%20final_0.pdf."},{"key":"10.1016\/j.vaccine.2019.01.011_b0520","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1016\/S0264-410X(03)00357-8","article-title":"Maternal immunization: US FDA regulatory considerations","volume":"21","author":"Gruber","year":"2003","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2019.01.011_b0525","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.vaccine.2014.12.068","article-title":"Regulatory considerations in the clinical development of vaccines indicated for use during pregnancy","volume":"33","author":"Roberts","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.011_b0530","unstructured":"World Health Organization (WHO). Guidelines on clinical evaluation of vaccines: regulatory expectations, WHO Technical Report Series, No.1004; 2017."},{"key":"10.1016\/j.vaccine.2019.01.011_b0535","unstructured":"HHS, FDA, CBER, CDER. Guidance for industry: M3(R2) Nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals; 2010. Available from: https:\/\/www.fda.gov\/downloads\/drugs\/guidances\/ucm073246.pdf. The FDA also circulated draft guidance for comment on this topic in April 2018. The guidance was not yet finalized at the time this report was completed."},{"issue":"4","key":"10.1016\/j.vaccine.2019.01.011_b0540","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1586\/erv.12.6","article-title":"Review of the risks and benefits of yellow fever vaccination including some new analyses","volume":"11","author":"Monath","year":"2012","journal-title":"Expert Rev Vaccines"},{"issue":"31","key":"10.1016\/j.vaccine.2019.01.011_b0545","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1016\/j.vaccine.2018.05.117","article-title":"Declining responsiveness to influenza vaccination with progression of human pregnancy","volume":"36","author":"Schlaudecker","year":"2018","journal-title":"Vaccine"},{"issue":"51","key":"10.1016\/j.vaccine.2019.01.011_b0550","doi-asserted-by":"crossref","first-page":"8073","DOI":"10.1016\/j.vaccine.2010.10.015","article-title":"Is it time for a new yellow fever vaccine?","volume":"28","author":"Hayes","year":"2010","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2019.01.011_b0555","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJMoa1009303","article-title":"An inactivated cell-culture vaccine against yellow fever","volume":"364","author":"Monath","year":"2011","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2019.01.011_b0560","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003693","article-title":"A DNA vaccine against yellow fever virus: development and evaluation","volume":"9","author":"Maciel","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"35","key":"10.1016\/j.vaccine.2019.01.011_b0565","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1016\/j.vaccine.2015.03.077","article-title":"An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures","volume":"33","author":"Pereira","year":"2015","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2019.01.011_b0570","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1586\/14760584.2015.1083430","article-title":"Current status and future prospects of yellow fever vaccines","volume":"14","author":"Beck","year":"2015","journal-title":"Expert Rev Vaccines"},{"issue":"10028","key":"10.1016\/j.vaccine.2019.01.011_b0575","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/S0140-6736(16)30195-7","article-title":"Yellow fever vaccine supply: a possible solution","volume":"387","author":"Monath","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.01.011_b0580","doi-asserted-by":"crossref","first-page":"664","DOI":"10.7326\/M17-1337","article-title":"Yellow fever vaccine shortages in the United States and abroad: a critical issue","volume":"167","author":"Lucey","year":"2017","journal-title":"Ann Int Med"},{"key":"10.1016\/j.vaccine.2019.01.011_b0585","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1038\/4031","article-title":"In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus model","volume":"4","author":"Mandl","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2019.01.011_b0590","doi-asserted-by":"crossref","unstructured":"Geall AJ, Mandl CW, Ulmer JB. RNA: The new revolution in nucleic acid vaccines. Semin Immunol. 25(2): 152\u2013159.","DOI":"10.1016\/j.smim.2013.05.001"},{"issue":"3","key":"10.1016\/j.vaccine.2019.01.011_b0595","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0035-9203(93)90156-K","article-title":"Yellow fever vaccination and pregnancy: a four-year prospective study","volume":"87","author":"Nasidi","year":"1993","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2019.01.011_b0600","unstructured":"Clinical development and requirements for licensure of vaccines intended for use during pregnancy to prevent disease in the infant -- FDA briefing document vaccines and related biological products advisory committee meeting [Internet]. 2015. Available from: https:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/BloodVaccinesandOtherBiologics\/VaccinesandRelatedBiologicalProductsAdvisoryCommittee\/UCM472056.pdf."},{"issue":"49","key":"10.1016\/j.vaccine.2019.01.011_b0605","doi-asserted-by":"crossref","first-page":"5993","DOI":"10.1016\/j.vaccine.2016.07.006","article-title":"Global alignment of immunization safety assessment in pregnancy\u2014The GAIA project","volume":"34","author":"Bonhoeffer","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.011_b0610","unstructured":"Global alignment of immunization safety assessment in pregnancy (GAIA). http:\/\/gaia-consortium.net\/."},{"key":"10.1016\/j.vaccine.2019.01.011_b0615","unstructured":"World Health Organization (WHO). Global vaccine advisory committee on vaccine safety. Safety of immunization during pregnancy: a review of the evidence. World Health Organization; 2014."},{"issue":"23","key":"10.1016\/j.vaccine.2019.01.011_b0620","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1056\/NEJM199906103402304","article-title":"Time of implantation of the conceptus and loss of pregnancy","volume":"340","author":"Wilcox","year":"1999","journal-title":"N Engl J Med"},{"issue":"340","key":"10.1016\/j.vaccine.2019.01.011_b0625","article-title":"Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials","volume":"2","author":"Wacholder","year":"2010","journal-title":"BMJ"},{"issue":"351","key":"10.1016\/j.vaccine.2019.01.011_b0630","article-title":"Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial","volume":"1","author":"Panagiotou","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2019.01.011_b0635","unstructured":"U.S. Department of Health and Human Services (HHS). Code of federal regulations: title 45, Part 46, protection of human subjects [Internet]. 2009 [cited 2017 Apr 10]. Available from: https:\/\/www.hhs.gov\/ohrp\/regulations-and-policy\/regulations\/45-cfr-46\/. *Note: HHS and 15 other federal agencies issued a final rule to update these regulations on January 18, 2017, with most of the new provisions scheduled to go into effect in January 2019. See: https:\/\/www.hhs.gov\/ohrp\/regulations-and-policy\/regulations\/finalized-revisions-common-rule\/index.html."},{"key":"10.1016\/j.vaccine.2019.01.011_b0640","series-title":"Clinical research involving pregnant women","first-page":"161","article-title":"When hypothetical vulnerability becomes actual: research participation and the autonomy of pregnant women","author":"Johnson","year":"2016"},{"issue":"3","key":"10.1016\/j.vaccine.2019.01.011_b0645","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11017-013-9258-0","article-title":"The perils of protection: vulnerability and women in clinical research","volume":"34","author":"Schonfeld","year":"2013","journal-title":"Theor Med Bioeth"},{"key":"10.1016\/j.vaccine.2019.01.011_b0650","unstructured":"National Committee of BioEthics of Saudi Arabia. Implementing regulations of the law of ethics of research on living creatures: second edition; 2016."},{"key":"10.1016\/j.vaccine.2019.01.011_b0655","unstructured":"Uganda National Council on Science and Technology (UNCST). National guidelines for research involving humans as research participants. Kampala, Uganda. July 2014."},{"issue":"3","key":"10.1016\/j.vaccine.2019.01.011_b0660","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12978-017-0421-3","article-title":"Ethics, regulation, and beyond: the landscape of research with pregnant women","volume":"14","author":"Saenz","year":"2017","journal-title":"Reprod Health"},{"issue":"5","key":"10.1016\/j.vaccine.2019.01.011_b0665","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1086\/381709","article-title":"What makes clinical research in developing countries ethical? the benchmarks of ethical research","volume":"189","author":"Emanuel","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.01.011_b0670","unstructured":"World Health Organization (WHO). Good participatory practice guidelines for trials of emerging (and re-emerging) pathogens that are likely to cause severe outbreaks in the near future and for which few or no medical countermeasures exist (GPP-EP). [DRAFT] Dec 2016. [Internet]. 2016. Available from: http:\/\/www.who.int\/csr\/research-and-development\/documents\/GPP-EP-Dec-2016.pdf."},{"issue":"4","key":"10.1016\/j.vaccine.2019.01.011_b0675","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010790","article-title":"Factors influencing women\u2019s attitudes towards antenatal vaccines, group B Streptococcus and clinical trial participation in pregnancy: an online survey","volume":"6","author":"McQuaid","year":"2016","journal-title":"BMJ Open"},{"issue":"suppl 7","key":"10.1016\/j.vaccine.2019.01.011_b0680","doi-asserted-by":"crossref","first-page":"S400","DOI":"10.1093\/cid\/ciu726","article-title":"Recruitment and retention of pregnant women into clinical research trials: an overview of challenges, facilitators, and best practices","volume":"59","author":"Frew","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"47","key":"10.1016\/j.vaccine.2019.01.011_b0685","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1016\/j.vaccine.2015.08.042","article-title":"Moving targets: The challenges of studying infectious diseases among pregnant women in resource limited settings","volume":"33","author":"Divala","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.011_b0690","unstructured":"World Health Organization (WHO). Draft Ebola\/Marburg research and development (R&D) Roadmap. p.3-4. Posted May 2018. Accessed 7 Aug 2018. Available from: http:\/\/www.who.int\/blueprint\/priority-diseases\/key-action\/Ebola-Marburg_Draft_Roadmap_publiccomment_MAY2018.pdf."},{"key":"10.1016\/j.vaccine.2019.01.011_b0695","unstructured":"World Health Organization (WHO). Draft roadmap for research and product development against crimean-congo haemorrhagic fever (CCHF). p.10. Posted 19 June 2018. Accessed 7 Aug 2018. Available from: http:\/\/www.who.int\/blueprint\/priority-diseases\/key-action\/cchf-draft-r-and-d-roadmap.pdf."},{"key":"10.1016\/j.vaccine.2019.01.011_b0700","unstructured":"Centers for Disease Control (CDC). Guidelines for vaccinating pregnant women (internet). 2016. Accessed August 1, 2018. Available from: https:\/\/www.cdc.gov\/vaccines\/pregnancy\/hcp\/guidelines.html."},{"key":"10.1016\/j.vaccine.2019.01.011_b0705","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1365-3156.2007.01851.x","article-title":"Early exposure to yellow fever vaccine during pregnancy","volume":"12","author":"Cavalcanti","year":"2007","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.vaccine.2019.01.011_b0710","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.vaccine.2005.09.033","article-title":"The effects of yellow fever immunization (17DD) inadvertently used in early pregnancy during a mass campaign in Brazil","volume":"24","author":"Suzano","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.011_b0715","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1365-3156.1998.00164.x","article-title":"Yellow fever vaccination during pregnancy and spontaneous abortion: a case-control study","volume":"3","author":"Nishioka Sde","year":"1998","journal-title":"Trop Med Int Health"},{"issue":"5","key":"10.1016\/j.vaccine.2019.01.011_b0720","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/infdis\/142.5.776","article-title":"From the center for disease control. Current status of rubella in the United States, 1969\u20131979","volume":"142","author":"Preblud","year":"1980","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2019.01.011_b0725","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/AOG.0000000000000857","article-title":"Risks associated with smallpox vaccination in pregnancy: a systematic review and meta-analysis","volume":"125","author":"Badell","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"10068","key":"10.1016\/j.vaccine.2019.01.011_b0730","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola \u00c7a Suffit!)","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2019.01.011_b0735","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/15265160601021256","article-title":"Ethics and public health emergencies: rationing vaccines","volume":"6","author":"Wynia","year":"2006","journal-title":"Am J Bioeth"},{"key":"10.1016\/j.vaccine.2019.01.011_b0740","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2471\/BLT.12.113480","article-title":"Ethical considerations for vaccination programmes in acute humanitarian emergencies","volume":"91","author":"Moodley","year":"2013","journal-title":"Bull World Health Organ"},{"issue":"11","key":"10.1016\/j.vaccine.2019.01.011_b0745","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/j.vaccine.2006.11.045","article-title":"Rationing of influenza vaccine during a pandemic: ethical analyses","volume":"25","author":"Zimmerman","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2019.01.011_b0750","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/1471-2458-7-236","article-title":"Prioritization strategies for pandemic influenza vaccine in 27 countries of the European union and the global health security action group: a review","volume":"7","author":"Straetemans","year":"2007","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2019.01.011_b0755","unstructured":"Committee for Medicinal Products for Human Use (CHMP). Guideline on the exposure to medicinal products during pregnancy: need for post-authorisation data. European medicines agency; 2005. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Regulatory_and_procedural_guideline\/2009\/11\/WC500011303.pdf."},{"key":"10.1016\/j.vaccine.2019.01.011_b0760","unstructured":"U.S. Food and Drug Administration (FDA), center for biologics evaluation and research. Guidance for industry postmarketing studies and clinical trials \u2014 implementation of section 505(o)(3) of the Federal Food, Drug, and Cosmetic Act 2011. [Internet]; 2011. Available from: https:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM172001.pdf."},{"issue":"23","key":"10.1016\/j.vaccine.2019.01.011_b0765","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1016\/j.vaccine.2017.04.058","article-title":"Challenges in conducting post-authorisation safety studies (PASS): A vaccine manufacturer\u2019s view","volume":"35","author":"Cohet","year":"2017","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2019.01.011_b0770","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1473-3099(16)30523-0","article-title":"Safety of a killed oral cholera vaccine (Shanchol) in pregnant women in Malawi: an observational cohort study","volume":"17","author":"Ali","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.01.011_b0775","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004274","article-title":"Pregnancy outcomes after a mass vaccination campaign with an oral cholera vaccine in Guinea: a retrospective cohort study","volume":"9","author":"Grout","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2019.01.011_b0780","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.vaccine.2017.01.080","article-title":"Safety of the oral cholera vaccine in pregnancy: Retrospective findings from a subgroup following mass vaccination campaign in Dhaka, Bangladesh","volume":"35","author":"Khan","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.011_b0785","unstructured":"European Medicines Agency (EMA). Post-authorisation measures: questions and answers [Internet]. Available from: http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/regulation\/q_and_a\/q_and_a_detail_000037.jsp&mid=WC0b01ac0580023e7a."},{"key":"10.1016\/j.vaccine.2019.01.011_b0790","unstructured":"European Medicines Agency (EMA). Conditional marketing authorisation [Internet]. Available from: http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/regulation\/general\/general_content_000925.jsp&mid=WC0b01ac05809f843b)."},{"key":"10.1016\/j.vaccine.2019.01.011_b0795","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1126\/science.1145067","article-title":"Willingness to donate frozen embryos for stem cell research","volume":"317","author":"Lyerly","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2019.01.011_b0800","unstructured":"World Health Organization (WHO). Cholera vaccines: WHO position paper\u2013August 2017. Weekly Epidemiological Record. 2017 Aug 25;92(34):477\u201398."},{"issue":"1","key":"10.1016\/j.vaccine.2019.01.011_b0805","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/ajmg.a.30225","article-title":"Pregnancy outcome following rubella vaccination: A prospective controlled study","volume":"130A","author":"Bar-Oz","year":"2004","journal-title":"Am J Med Genet A"},{"issue":"4","key":"10.1016\/j.vaccine.2019.01.011_b0810","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0002-9378(73)90112-9","article-title":"Inadvertent rubella immunization in pregnancy","volume":"117","author":"Ebbin","year":"1973","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.vaccine.2019.01.011_b0815","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1001\/jama.1973.03220400018004","article-title":"Inadvertant rubella vaccination of pregnant women: fetal risk in 215 cases","volume":"225","author":"Wyll","year":"1973","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.vaccine.2019.01.011_b0820","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.vaccine.2014.10.047","article-title":"The complementary roles of Phase 3 trials and post-licensure surveillance in the evaluation of new vaccines","volume":"33","author":"Lopalco","year":"2015","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2019.01.011_b0825","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1053\/j.semperi.2015.08.005","article-title":"Vaccine monitoring systems: A potential model for medications in pregnancy","volume":"39","author":"Nesin","year":"2015","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.vaccine.2019.01.011_b0830","unstructured":"U.S. food and drug administration, center for biologics evaluation and research. The sentinel post-licensure rapid immunization safety monitoring (PRISM) system: public workshop. [Internet]; 2016. Available from: https:\/\/www.fda.gov\/BiologicsBloodVaccines\/NewsEvents\/WorkshopsMeetingsConferences\/ucm490175.htm."},{"key":"10.1016\/j.vaccine.2019.01.011_b0835","series-title":"Advances in patient safety: from research to implementation (volume 2: concepts and methodology)","article-title":"The brighton collaboration: creating a global standard for case definitions (and guidelines) for adverse events following immunization","author":"Kohl","year":"2005"},{"issue":"4","key":"10.1016\/j.vaccine.2019.01.011_b0840","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/pds.3754","article-title":"Adverse event following immunization surveillance systems for pregnant women and their infants: a systematic review","volume":"24","author":"Cassidy","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"10.1016\/j.vaccine.2019.01.011_b0845","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1080\/21645515.2016.1175697","article-title":"A global survey of adverse event following immunization surveillance systems for pregnant women and their infants","volume":"12","author":"Cassidy","year":"2016","journal-title":"Hum Vaccines Immunother"},{"issue":"47","key":"10.1016\/j.vaccine.2019.01.011_b0850","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.1016\/j.vaccine.2015.08.043","article-title":"A systematic review of adverse events following immunization during pregnancy and the newborn period","volume":"33","author":"Fulton","year":"2015","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.vaccine.2019.01.011_b0855","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJMra1509044","article-title":"Maternal immunization","volume":"376","author":"Omer","year":"2017","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2019.01.011_b0860","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/S0264-410X(01)00302-4","article-title":"Maternal Immunization: the influence of liability issues on vaccine development","volume":"20","author":"Paradiso","year":"2001","journal-title":"Vaccine"},{"issue":"47","key":"10.1016\/j.vaccine.2019.01.011_b0865","doi-asserted-by":"crossref","first-page":"6436","DOI":"10.1016\/j.vaccine.2015.08.035","article-title":"Maternal benefits of immunization during pregnancy","volume":"33","author":"Swamy","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2019.01.011_b0870","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/AOG.0000000000000581","article-title":"Vaccinations for pregnant women","volume":"125","author":"Swamy","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"10059","key":"10.1016\/j.vaccine.2019.01.011_b0875","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1016\/S0140-6736(16)30882-0","article-title":"Strengthening maternal immunization to improve the health of mothers and infants","volume":"388","author":"Abramson","year":"2016","journal-title":"The Lancet"},{"key":"10.1016\/j.vaccine.2019.01.011_b0880","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1016\/j.jinf.2016.04.027","article-title":"Maternal immunization: Optimizing protection for the mother and infant","volume":"72","author":"Kachikis","year":"2016","journal-title":"J Infect"},{"issue":"2","key":"10.1016\/j.vaccine.2019.01.011_b0885","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/GRF.0b013e31824f3acb","article-title":"Vaccines in pregnant women and research initiatives","volume":"55","author":"Healy","year":"2012","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2019.01.011_b0890","doi-asserted-by":"crossref","unstructured":"ACOGcommittee opinion no. 566: update on immunization and pregnancy: tetanus, diphtheria, and pertussis vaccination.ObstetGynecol 2013;121(6).","DOI":"10.1097\/01.AOG.0000431054.33593.e3"},{"key":"10.1016\/j.vaccine.2019.01.011_b0895","doi-asserted-by":"crossref","unstructured":"ACOGcommittee opinion no. 608: influenza vaccination during pregnancy.ObstetGynecol 2014;124(3).","DOI":"10.1097\/01.AOG.0000453599.11566.11"},{"key":"10.1016\/j.vaccine.2019.01.011_b0900","unstructured":"Maternal immunization working group. The national vaccine advisory committee: overcoming barriers and identifying opportunities for developing maternal immunizations [Internet]. HHS; 2016 Sep. Available from: https:\/\/www.hhs.gov\/sites\/default\/files\/nvacmaternalimmunization2016report.pdf."},{"key":"10.1016\/j.vaccine.2019.01.011_b0905","unstructured":"Gruber M. FDA update: vaccines for use in pregnancy to protect young infants from disease [Internet]. 2016 Jun 30. Available from: http:\/\/www.fda.gov\/AboutFDA\/Transparency\/Basics\/ucm508553.htm."},{"issue":"3","key":"10.1016\/j.vaccine.2019.01.011_b0910","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/ajmg.c.30313","article-title":"Evolving knowledge of the teratogenicity of medications in human pregnancy","volume":"157","author":"Adam","year":"2011","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.vaccine.2019.01.011_b0915","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fped.2014.00009","article-title":"Obstetric pharmacokinetic dosing studies are urgently needed","volume":"2","author":"McCormack","year":"2014","journal-title":"Front Pediatr"},{"key":"10.1016\/j.vaccine.2019.01.011_b0920","unstructured":"International Conference on Harmonisation (ICH) of technical requirements for registration of pharmaceuticals for human use. ICH tripartate guideline: guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals; 2009 June 11."},{"issue":"suppl 7","key":"10.1016\/j.vaccine.2019.01.011_b0925","doi-asserted-by":"crossref","first-page":"S437","DOI":"10.1093\/cid\/ciu709","article-title":"Designing drug trials: considerations for pregnant women","volume":"59","author":"Sheffield","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.01.011_b0930","series-title":"Clinical research involving pregnant women","first-page":"65","article-title":"Fair inclusion of pregnant women in clinical research: a systematic review of reported reasons for exclusion","author":"van der Zande","year":"2016"},{"issue":"15","key":"10.1016\/j.vaccine.2019.01.011_b0935","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1097\/QAD.0000000000001214","article-title":"Advancing HIV research with pregnant women: navigating challenges and opportunities","volume":"30","author":"Krubiner","year":"2016","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2019.01.011_b0940","series-title":"Feminism and bioethics: Beyond reproduction","first-page":"216","article-title":"Ethical obstacles to the participation of women in biomedical research","author":"Merton","year":"1996"},{"issue":"10","key":"10.1016\/j.vaccine.2019.01.011_b0945","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.2105\/AJPH.2009.165498","article-title":"The national children\u2019s study: a golden opportunity to advance the health of pregnant women","volume":"99","author":"Lyerly","year":"2009","journal-title":"Am J Public Health"},{"issue":"4","key":"10.1016\/j.vaccine.2019.01.011_b0950","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/jamapediatrics.2016.5046","article-title":"Acetaminophen in pregnancy and adverse childhood neurodevelopment","volume":"171","author":"Little","year":"2017","journal-title":"JAMA Pediatr"},{"issue":"6","key":"10.1016\/j.vaccine.2019.01.011_b0955","article-title":"Pregnancy and clinical research","volume":"38","author":"Lyerly","year":"2008","journal-title":"Hastings Cent Rep"},{"issue":"5","key":"10.1016\/j.vaccine.2019.01.011_b0960","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/15265161.2011.560353","article-title":"Reframing the framework: toward fair inclusion of pregnant women as participants in research","volume":"11","author":"Lyerly","year":"2011","journal-title":"Am J Bioeth"},{"key":"10.1016\/j.vaccine.2019.01.011_b0965","unstructured":"\u201cEnrolling pregnant women\u201d issues in clinical research: an ORWH research forum [Internet]. Office of research on women\u2019s health, national institutes of health; 2010 Oct. Available from: https:\/\/orwh.od.nih.gov\/resources\/pdf\/ORWH-EPW-Report-2010.pdf."},{"key":"10.1016\/j.vaccine.2019.01.011_b0970","unstructured":"Food and Drug Administration (FDA). Guidance for industry establishing pregnancy exposure registries [Internet]. Accessed August 1, 2018. Available from: https:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm071639.pdf."},{"issue":"26","key":"10.1016\/j.vaccine.2019.01.011_b0975","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1056\/NEJMsb031395","article-title":"Systematic identification of drugs that cause birth defects \u2014 a new opportunity","volume":"349","author":"Mitchell","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2019.01.011_b0980","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/sj.clpt.6100448","article-title":"Drug safety in pregnant women and their babies: ignorance not bliss","volume":"83","author":"Chambers","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.vaccine.2019.01.011_b0985","unstructured":"Charlton R, de Vries C. Systematic overview of data sources for drug safety in pregnancy research: Consultancy EMA\/2010\/29\/CN prepared for the European Medicines Agency, June 2012 updated forENCePPJune2016. University of Bath; 2016 Jun."},{"issue":"7","key":"10.1016\/j.vaccine.2019.01.011_b0990","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1053\/j.semperi.2015.08.004","article-title":"FDA drug labeling for pregnancy and lactation drug safety monitoring systems","volume":"39","author":"Greene","year":"2015","journal-title":"InSeminars Perinatol"},{"key":"10.1016\/j.vaccine.2019.01.011_b0995","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0074-7742(08)00017-2","article-title":"Chapter 17 pregnancy registries: strengths, weaknesses, and bias interpretation of pregnancy registry data","volume":"83","author":"Cunnington","year":"2008","journal-title":"Int Rev Neurobiol"},{"issue":"10","key":"10.1016\/j.vaccine.2019.01.011_b1000","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1089\/jwh.2011.3118","article-title":"Clinical research enrolling pregnant women: a workshop summary","volume":"20","author":"Foulkes","year":"2011","journal-title":"J Womens Health"},{"key":"10.1016\/j.vaccine.2019.01.011_b1005","unstructured":"FDA research, policy, and workshops on women in clinical trials [Internet]. 2016. Accessed August 1, 2018. Available from: https:\/\/www.fda.gov\/scienceresearch\/specialtopics\/womenshealthresearch\/ucm131731.htm."},{"key":"10.1016\/j.vaccine.2019.01.011_b1010","series-title":"Social justice: the moral foundations of public health and health policy","first-page":"258","author":"Powers","year":"2006"},{"issue":"11","key":"10.1016\/j.vaccine.2019.01.011_b1015","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.2105\/AJPH.91.11.1776","article-title":"An ethics framework for public health","volume":"91","author":"Kass","year":"2001","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2019.01.011_b1020","series-title":"The Stanford encyclopedia of philosophy","article-title":"Public health ethics","author":"Faden","year":"2016"},{"issue":"3","key":"10.1016\/j.vaccine.2019.01.011_b1025","first-page":"186","article-title":"Malaria and pregnancy: a global health perspective","volume":"2","author":"Schantz-Dunn","year":"2009","journal-title":"Rev Obstet Gynecol"},{"issue":"9492","key":"10.1016\/j.vaccine.2019.01.011_b1030","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0140-6736(05)67481-8","article-title":"Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study","volume":"366","author":"Gray","year":"2005","journal-title":"The Lancet"},{"issue":"12","key":"10.1016\/j.vaccine.2019.01.011_b1035","doi-asserted-by":"crossref","first-page":"e710","DOI":"10.1016\/S2214-109X(14)70330-4","article-title":"Tuberculosis in pregnancy: an estimate of the global burden of disease","volume":"2","author":"Sugarman","year":"2014","journal-title":"Lancet Glob Health"},{"issue":"1","key":"10.1016\/j.vaccine.2019.01.011_b1040","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1016\/j.whi.2012.10.003","article-title":"Enrolling pregnant women: issues in clinical research","volume":"23","author":"Blehar","year":"2013","journal-title":"Womens Health Issues"},{"issue":"2","key":"10.1016\/j.vaccine.2019.01.011_b1045","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3138\/ijfab.5.2.82","article-title":"How are pregnant women vulnerable research participants?","volume":"5","author":"Wild","year":"2012","journal-title":"Int J Fem Approaches Bioeth"},{"issue":"2","key":"10.1016\/j.vaccine.2019.01.011_b1050","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1353\/ken.2011.0007","article-title":"A framework for risk-benefit evaluations in biomedical research","volume":"21","author":"Rid","year":"2011","journal-title":"Kennedy Inst Ethics J"},{"issue":"3","key":"10.1016\/j.vaccine.2019.01.011_b1055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2307\/3527551","article-title":"Swinging on the pendulum: shifting views of justice in human subjects research","volume":"31","author":"Mastroianni","year":"2001","journal-title":"Hastings Cent Rep"},{"key":"10.1016\/j.vaccine.2019.01.011_b1060","series-title":"Women and health research ethical and legal issues of including women in clinical studies","first-page":"297","author":"Mastroianni","year":"1994"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19300453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19300453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:51:08Z","timestamp":1759402268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19300453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":212,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0264410X19300453"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.01.011","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Pan American Health Organization. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}